A randomized, double‐blind, 24‐week controlled study of low‐dose cyclosporine versus chloroquine for early rheumatoid arthritis

Arthritis & Rheumatism

Volumn 37, Issue 5, 1994, Pages 637-643

  Landewé, ROBERT B M ^a   Goeithè, Henk S ^b   Van Rijthoven, ANDRE W A M ^c   Breedveld, Ferdinand C ^a   Dijkmans, BEN A C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASLAND HOSPITAL   (Netherlands)

^c Deaconess Hospital   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; C REACTIVE PROTEIN; CHLOROQUINE; CREATININE; CYCLOSPORIN A; LIVER ENZYME; MAGNESIUM; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM; SODIUM; URIC ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GASTROINTESTINAL SYMPTOM; GINGIVA HYPERPLASIA; HUMAN; HYPERKALEMIA; HYPERTRICHOSIS; HYPOMAGNESEMIA; KIDNEY DISEASE; MALE; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RHEUMATOID ARTHRITIS; SYSTOLIC BLOOD PRESSURE; TREMOR;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BLOOD PRESSURE; CHLOROQUINE; CREATININE; CYCLOSPORINE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 23444449002     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780370506     Document Type: Article

References (30)

1. Practical results of treatment with disease modifying antirheumatoid drugs
2. Cyclosporin
3. Cyclosporin treatment of rheumatoid arthritis: a placebo controlled, double blind, multicentre study
4. Cyclosporin A treatment of refractory rheumatoid arthritis
5. An open, controlled, randomized comparison of cyclosporine and azathioprine in the treatment of rheumatoid arthritis: a preliminary report
6. Cyclosporin A in severe, treatment refractory rheumatoid arthritis: a randomized study
7. Low‐dose cyclosporin versus placebo in patients with rheumatoid arthritis
8. Comparison of cyclosporine and D‐penicillamine for rheumatoid arthritis: a randomized, double‐blind study
9. Cyclosporin in rheumatoid arthritis: a double blind, placebo controlled study in 52 patients
10. Side effects of cyclosporin A treatment in patients with rheumatoid arthritis
11. Effect of cyclosporine on serum creatinine in patients with rheumatoid arthritis
12. Serum creatinine levels two years later: follow up of a placebo controlled trial of cyclosporine in rheumatoid patients
13. Assessment of efficacy and acceptability of low dose cyclosporin in patients with rheumatoid arthritis
14. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis
15. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
16. A comparison of two dose levels of hydroxychloroquine in rheumatoid arthritis
17. Hydroxychloroquine sulphate in the treatment of rheumatoid arthritis: a double blind comparison of two dose regimens
18. A controlled study of chloroquine as an antirheumatic agent
19. Chloroquine diphosphate in rheumatoid arthritis: a controlled trial
20. Hydroxychloroquine sulfate (“plaquenil”) in treatment of rheumatoid arthritis
21. Hydroxychloroquine sulphate in rheumatoid arthritis: a six month, double‐blind trial
22. A double‐blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine
23. Chloroquine therapy in rheumatoid arthritis
24. Chloroquine in rheumatoid arthritis: a double blindfold trial of treatment for one year
25. Antimalarials in rheumatology: efficacy and safety
26. Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents
27. Immunosuppressive potential of anti‐malarials
28. Cyclosporine and chloroquine synergistically inhibit the interferon gamma production by CD4 positive and CD8 positive T‐cell clones derived from a patient with rheumatoid arthritis
29. Chloroquine serum concentration and side effects: evidence for dose dependent kinetics
30. Cyclosporine in rheumatoid arthritis, anno 1990